{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T19:03:12Z","timestamp":1793905392244,"version":"4.8.0"},"reference-count":26,"publisher":"American Society of Hematology","issue":"14","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2009,4,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Montreal platelet syndrome (MPS), hitherto described in only one kindred, is a hereditary thrombocytopenia associated with mucocutaneous bleeding, giant platelets, and spontaneous platelet aggregation in vitro. These are features shared with some forms of type 2B von Willebrand disease (VWD); however, the MPS kindred had not been investigated for VWD. We found that all affected MPS family members had borderline to normal von Willebrand factor antigen (VWF:Ag; 0.43-0.75 U\/mL), discrepantly low ristocetin cofactor activity (VWF:RCo; 0.16-0.29 U\/mL), and normal factor VIII coagulant activity (FVIII:C; 0.57-1.04 U\/mL). Unaffected family members all had normal VWF:Ag, VWF:RCo, and FVIII:C levels. In addition, persons with MPS, but not unaffected family members, had loss of plasma (but not platelet) high molecular weight VWF multimers, and were heterozygous for the previously reported V1316M type 2B VWD mutation. Thus, in reevaluating this kindred, we determined that patients with MPS have type 2B VWD with the V1316M VWF mutation.<\/jats:p>","DOI":"10.1182\/blood-2008-06-165233","type":"journal-article","created":{"date-parts":[[2008,12,6]],"date-time":"2008-12-06T02:24:30Z","timestamp":1228530270000},"page":"3348-3351","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":47,"title":["The Montreal platelet syndrome kindred has type 2B von Willebrand disease with the VWF V1316M mutation"],"prefix":"10.1182","volume":"113","author":[{"given":"Shannon C.","family":"Jackson","sequence":"first","affiliation":[{"name":"Division of Hematology and Hematologic Malignancies, Department of Medicine, University of Calgary, Calgary, AB;"},{"name":"Calgary Health Region, Calgary, AB;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary D.","family":"Sinclair","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, University of Calgary, Calgary, AB;"},{"name":"Molecular Hematology, Calgary Laboratory Services, Calgary, AB;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Cloutier","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine, Universit\u00e9 Laval and CHA-H\u00f4pital de l'Enfant-Jesus, Quebec City, QC;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoxia","family":"Duan","sequence":"additional","affiliation":[{"name":"Division of Hematology and Hematologic Malignancies, Department of Medicine, University of Calgary, Calgary, AB;"},{"name":"Calgary Health Region, Calgary, AB;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret L.","family":"Rand","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology, The Hospital for Sick Children, Toronto, ON; and"},{"name":"Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Man-Chiu","family":"Poon","sequence":"additional","affiliation":[{"name":"Division of Hematology and Hematologic Malignancies, Department of Medicine, University of Calgary, Calgary, AB;"},{"name":"Calgary Health Region, Calgary, AB;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111716140454000_B1","first-page":"611","article-title":"Etudes sur une thrombopathie familiale.","volume":"3","author":"Lacombe","year":"1963","journal-title":"Nouv Rev Fr Hematol"},{"key":"2019111716140454000_B2","first-page":"154","article-title":"Shape-changing agents produce abnormally large platelets in a hereditary \u201cgiant platelets syndrome (MPS).\u201d","volume":"93","author":"Milton","year":"1979","journal-title":"J Lab Clin Med"},{"key":"2019111716140454000_B3","first-page":"326","article-title":"Platelet size and shape in hereditary giant platelet syndromes on blood smear and in suspension: evidence for two types of abnormalities.","volume":"106","author":"Milton","year":"1985","journal-title":"J Lab Clin Med"},{"key":"2019111716140454000_B4","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1080\/09537100500441150","article-title":"Von Willebrand disease type 2B must be always considered in the differential diagnosis of genetic thrombocytopenia with giant platelets.","volume":"17","author":"Loffredo","year":"2006","journal-title":"Platelets"},{"key":"2019111716140454000_B5","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/ajh.2830270412","article-title":"Type IIB von Willebrand's disease associated with a complex thrombocytopenic thrombocytopathy.","volume":"27","author":"Lopez-Fernandez","year":"1988","journal-title":"Am J Hematol"},{"key":"2019111716140454000_B6","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/(SICI)1096-8652(199801)57:1<62::AID-AJH11>3.0.CO;2-B","article-title":"Giant platelet disorder in a patient with type 2B von Willebrand's disease.","volume":"57","author":"Moll","year":"1998","journal-title":"Am J Hematol"},{"key":"2019111716140454000_B7","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1182\/blood.V66.2.282.282","article-title":"Type IIB Tampa: a variant of von Willebrand disease with chronic thrombocytopenia, circulating platelet aggregates, and spontaneous platelet aggregation.","volume":"66","author":"Saba","year":"1985","journal-title":"Blood"},{"key":"2019111716140454000_B8","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1046\/j.1365-2141.2000.02246.x","article-title":"Platelet ultrastructural abnormalities in three patients with type 2B von Willebrand disease.","volume":"110","author":"Nurden","year":"2000","journal-title":"Br J Haematol"},{"key":"2019111716140454000_B9","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1172\/JCI112132","article-title":"von Willebrand's disease with spontaneous platelet aggregation induced by an abnormal plasma von Willebrand factor.","volume":"76","author":"Gralnick","year":"1985","journal-title":"J Clin Invest"},{"key":"2019111716140454000_B10","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.3324\/haematol.11256","article-title":"Inherited thrombocytopenias.","volume":"92","author":"Nurden","year":"2007","journal-title":"Haematologica"},{"key":"2019111716140454000_B11","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1538-7836.2003.00523.x","article-title":"Type IIb von Willebrand disease: a paradox explains how von Willebrand factor works.","volume":"2","author":"Ruggeri","year":"2003","journal-title":"J Thromb Haemost"},{"key":"2019111716140454000_B12","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1056\/NEJM198005083021902","article-title":"Heightened interaction between platelets and factor VIII\/von Willebrand factor in a new subtype of von Willebrand's disease.","volume":"302","author":"Ruggeri","year":"1980","journal-title":"N Engl J Med"},{"key":"2019111716140454000_B13","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1172\/JCI109795","article-title":"Variant von Willebrand's disease: characterization of two subtypes by analysis of multimeric composition of factor VIII\/von Willebrand factor in plasma and platelets.","volume":"65","author":"Ruggeri","year":"1980","journal-title":"J Clin Invest"},{"key":"2019111716140454000_B14","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1172\/JCI115122","article-title":"Molecular basis of von Willebrand disease type IIB: Candidate mutations cluster in one disulfide loop between proposed platelet glycoprotein Ib binding sequences.","volume":"87","author":"Randi","year":"1991","journal-title":"J Clin Invest"},{"key":"2019111716140454000_B15","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1055\/s-2006-947870","article-title":"Genetic testing for von Willebrand disease: the Canadian experience.","volume":"32","author":"James","year":"2006","journal-title":"Semin Thromb Hemost"},{"key":"2019111716140454000_B16","first-page":"336","article-title":"Spontaneous platelet aggregation in a hereditary giant platelet syndrome (MPS).","volume":"114","author":"Milton","year":"1984","journal-title":"Am J Pathol"},{"key":"2019111716140454000_B17","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1365-2141.1983.tb01237.x","article-title":"Electroblotting of factor FVIII\/von Willebrand factor multimers after electrophoresis in SDS-agarose gel, discontinuous buffer system.","volume":"55","author":"Battle","year":"1983","journal-title":"Br J Haematol"},{"key":"2019111716140454000_B18","article-title":"University of Sheffield ISTH VWF SSC Information.","author":"Hampshire"},{"key":"2019111716140454000_B19","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1182\/blood.V79.8.2048.2048","article-title":"Expressed full-length von Willebrand factor containing missense mutations linked to type IIB von Willebrand disease shows enhanced binding to platelets.","volume":"79","author":"Kroner","year":"1992","journal-title":"Blood"},{"key":"2019111716140454000_B20","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/j.1365-2141.1991.tb08089.x","article-title":"Recurring mutations at CpG dinucleotides in the region of the von Willebrand factor gene encoding the glycoprotein Ib binding domain, in patients with IIB von Willebrand's disease.","volume":"79","author":"Lillicrap","year":"1991","journal-title":"Br J Haematol"},{"key":"2019111716140454000_B21","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/(SICI)1096-8652(199809)59:1<57::AID-AJH11>3.0.CO;2-Z","article-title":"Search for mutations in a segment of the exon 28 of the human von Willebrand factor gene: new mutations, R1315C and R1341W, associated with type 2M and 2B variants.","volume":"59","author":"Casana","year":"1998","journal-title":"Am J Hematol"},{"key":"2019111716140454000_B22","first-page":"199","article-title":"Germ-Line mosaicism for a valine-to-methionine substitution at residue 553 in the glycoprotein Ib-binding domain of von Willebrand factor, causing type IIB von Willebrand disease.","volume":"50","author":"Murray","year":"1992","journal-title":"Am J Hum Genet"},{"key":"2019111716140454000_B23","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/s002770100303","article-title":"Type 2B von Willebrand's disease due to Val1316Met mutation. Heterogeneity in the same sibship.","volume":"80","author":"Rendal","year":"2001","journal-title":"Ann Hematol"},{"key":"2019111716140454000_B24","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1182\/blood-2006-03-009449","article-title":"Impaired megakaryocytopoiesis in type 2B von Willebrand disease with severe thrombocytopenia.","volume":"108","author":"Nurden","year":"2006","journal-title":"Blood"},{"key":"2019111716140454000_B25","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1182\/blood.V74.2.715.715","article-title":"Montreal platelet syndrome: a defect in calpain-activated neutral proteinase (Calpain).","volume":"74","author":"Okita","year":"1989","journal-title":"Blood"},{"key":"2019111716140454000_B26","article-title":"Clinical and molecular predictors of thrombocytopenia and risk of bleeding in patients with von Willebrand disease type 2B: a cohort study of 67 patients.","author":"Federici","journal-title":"Blood"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/113\/14\/3348\/1305182\/zh801409003348.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/113\/14\/3348\/1305182\/zh801409003348.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,17]],"date-time":"2019-11-17T21:14:14Z","timestamp":1574025254000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/113\/14\/3348\/24822\/The-Montreal-platelet-syndrome-kindred-has-type-2B"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4,2]]},"references-count":26,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2009,4,2]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2008-06-165233","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,4,2]]}}}